Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements
暂无分享,去创建一个
A. Zander | B. Fehse | K. Kühlcke | F. Ayuk | Z. Li | C. Lindemann | U. Schade | H. Eckert | F. Ayuk | A. Zander
[1] T. Barbui,et al. Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells , 1998, British journal of haematology.
[2] A. Zander,et al. Highly‐efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin , 1998, British journal of haematology.
[3] David A. Williams,et al. High-Efficiency Gene Transfer into Normal and Adenosine Deaminase-Deficient T Lymphocytes Is Mediated by Transduction on Recombinant Fibronectin Fragments , 1998, Journal of Virology.
[4] A. Zander,et al. Impact of a new generation of gene transfer markers on gene therapy , 1998, Gene Therapy.
[5] A. Zander,et al. High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes. , 1998, Advances in experimental medicine and biology.
[6] S. Hegewisch-Becker,et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. , 1998, Human gene therapy.
[7] A. Zander,et al. Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene. , 1997, Human gene therapy.
[8] C. Bordignon,et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.
[9] R. Morgan,et al. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. , 1997, Blood.
[10] T. Kipps,et al. Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Morgan,et al. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. , 1996, Human gene therapy.
[12] David A. Williams,et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.
[13] E. Böhnlein,et al. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. , 1995, Gene therapy.
[14] S. Rosenberg,et al. T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.
[15] R. Morgan,et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Krance,et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.
[17] Daniel G. Miller,et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Garcia,et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.
[19] A. Miller,et al. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.